International Business Machines Corporation

Yangtze River Pharmaceutical Group Co., Ltd.

Shanghai Haiyan Pharmaceutical Technology Co., Ltd.

Huawei Technologies Co., Limited

Dong Huang

Kai Ye

Jiong Lan

Jing Xie

Fusheng Zhou

Jinzhu Zhao

Kai Zhang

Lei Zhang

Cheng Yi Huang

Yang Liu

Yuan Jin

Xiang Chen

Deng Peng Zhou

Shuchun Guo

Fang Rui Shu

Wan He

Shao Feng Shi

Changjiang Qiao

Dale M Schultz

Yi Hu

Yan Min Sheng

Qiang Lv

Yang Gu

Xi Chen

An anti-interference circuit board and a terminal, where the anti-interference circuit board includes a substrate having a first surface and a first region for placing a magnetometer is disposed on the first surface. A plurality of circuit layers are disposed in the substrate in a stacked manner. The first functional circuit and the second functional circuit are disposed to compensate for interference to the magnetometer in the first region, and during disposing, the first functional circuit and the second functional circuit are located below the magnetometer to reduce an occupied surface area of the anti-interference circuit board.

Anti-interference circuit board and terminal

The present invention relates to a 1,2-dihydropyrrol[3,4-c]pyridin/pyrimidin-3-one derivative substituted by N-(3-aminophenyl)acrylamide and a preparation method and pharmaceutical use thereof. In particular, the present invention relates to a compound of formula (II) or a pharmaceutically acceptable salt, stereoisomer, solvate, or prodrug thereof and a preparation method and application of the same. The definition of each substituent in the formula is described in detail in the specification and claims. 

Aniline-substituted 1,2-dihydropyrrol[3,4-C]pyridin/pyrimidin-3-one derivative and use thereof

The present disclosure relates to 4,6,7-trisubstituted 1,2-dihydropyrrolo[3,4-c]pyridin/pyrimidin-3-one derivatives, and their preparations and medicinal use. Specifically, the present disclosure discloses a compound of formula (I) or a pharmaceutically acceptable salt, stereoisomer, solvate or prodrug thereof, and a preparation method and use thereof, wherein the definition of each group is as described in the specification and claims. 

4,6,7-trisubstituted 1,2-dihydropyrrolo[3,4-c]pyridin/pyrimidin-3-one derivatives and uses thereof

The present invention discloses an N-sulfonyl benzamide derivative with a heterocyclic substituent, and a preparation method therefor and a pharmaceutical application thereof. More specifically, the invention discloses a compound represented by formula (II) or a pharmaceutically acceptable salt, stereoisomer, solvent compound, or prodrug thereof, and a preparation method therefor and an application thereof. Refer to the specification for definitions of each group in the formula. 

N-sulfonyl benzamides as voltage-gated sodium channel inhibitors

A method for assisting graphical user interface design includes extracting a first interface element from a first GUI under a first cultural background; searching in a rule repository for at least one transformation rule corresponding to the first interface element, where each of the at least one transformation rule includes at least an action taken on the first interface element; based on the at least one transformation rule, transforming the first interface element into a second interface element under a second cultural background; and providing a second user interface comprising at least the second interface element.

Assisting graphical user interface design

An emotion script generating method includes receiving a user's emotion data, and generating emotion script using the emotion data based on a predefined template.

Emotion script generating, experiencing, and emotion interaction

An emotion script generating apparatus, comprising means to receive emotion data, in which the emotion data is obtained according to measurable physiological parameters reflective of a user's emotions; and means to generate emotion script using the emotion data based on a predefined template. An emotion script experiencing apparatus, comprising means to receive emotion script, wherein the emotion script is generated using emotion data and is based on a predefined template, the emotion data capable of being obtained according to measurable physiological parameters reflective of a user's emotions; and means to affect a user by using emotion data extracted from the emotion script, so as to cause the user to experience the emotion script.

An apparatus for cross-browser testing of a web application is disclosed, including: a first broker residing among a plurality of browsers for receiving information of a user action from a browser operated by a user among the plurality of browsers and for transmitting the information of the user action to other browsers so that the other browsers can execute the user action; a second broker residing between the plurality of browsers and the web application for receiving at least one web request generated by executing the user action from the plurality of browsers and for determining whether to be able to merge the at least one web request, so as to determine whether the plurality of browsers are compatible with the web application. An associated method is also provided.

Cross-browser testing of a web application

Growing community of inventors

Shanghai, China

Dong Huang